Where 10x Genomics Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 10x Genomics (NASDAQ:TXG) has been rated by 7 analysts, with 2 being bullish, 4 somewhat bullish, and 1 bearish. The average 12-month price target for the stock has increased by 19.94% from the previous average, now standing at $60.57.
July 13, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
10x Genomics has received mostly bullish ratings from analysts, and the average 12-month price target has increased significantly.
The majority of analysts have given 10x Genomics a bullish or somewhat bullish rating, indicating a positive outlook for the stock. Additionally, the significant increase in the average 12-month price target suggests that analysts expect the stock's price to rise in the future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100